v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue    
Product sales, net $ 1,805,605 $ 3,688,988
Cost of products sold 562,676 1,402,285
Gross profit 1,242,929 2,286,703
Selling, general and administrative expenses 3,018,780 2,707,620
Research and development expenses 225,817 105,015
Total operating expenses 3,244,597 2,812,635
Loss from operations (2,001,668) (525,932)
Other expenses (1,700) (1,209)
Interest income 2,664 758
Loss before provision for income taxes and equity in net losses of equity investments (2,000,704) (526,383)
Provision for income taxes (11,464) (7,201)
Loss before equity in net losses of equity investments (2,012,168) (533,584)
Loss on earnings from China Joint Venture 36,783
Net loss (1,975,385) (577,985)
Net loss attributable to noncontrolling interests (101,407) (73,117)
Net loss attributable to Milestone Scientific Inc. $ (1,873,978) $ (504,868)
Net loss per share applicable to common stockholders—    
Basic (in dollars per share) $ (0.06) $ (0.02)
Diluted (in dollars per share) $ (0.06) $ (0.02)
Weighted average shares outstanding and to be issued—    
Basic (in shares) 34,766,014 32,004,548
Diluted (in shares) 34,766,014 32,004,548

Source